RIVAS MARIO (Chief Executive Officer) sold 2.9% of their position (3.57K shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $20.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/21/2022ACC: 0001209191-22-058112
DirectorOfficer· Chief Executive Officer
Since Feb 2020
-3.57K
Net shares
Net seller
$20.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.57K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.57K
Price / share
$5.67
Trade value
$20.26K
% of position
2.9%
11/17/2022
121.77K→118.20K
Total
Net shares
−3.57K
Net value
-$20.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2022 | S · Sale | −3.57K | $5.67 | $20.26K | 2.9% | 121.77K | 118.20K |
| Total | −3.57K | -$20.26K | ||||||
Derivative Transactions0
No derivative transactions reported